Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:32 am Sale |
2024-11-08 | 13G | Minerva Neurosciences, Inc. NERV |
FMR CORP | 0 0.000% |
-491,746 (Position Closed) |
Filing History |
| 2024-02-09 09:28 am Purchase |
2024-02-08 | 13G | Minerva Neurosciences, Inc. NERV |
FMR CORP | 491,746 7.031% |
491,746 (New Position) |
Filing History |
| 2024-01-18 10:21 am Purchase |
2023-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
FEDERATED HERMES INC. FHI |
1,351,275 19.320% |
150,000 (+12.49%) |
Filing History |
| 2023-07-07 4:18 pm Purchase |
2023-06-27 | 13D | Minerva Neurosciences, Inc. NERV |
Boehringer AG | 1,500,225 20.790% |
1,500,225 (New Position) |
Filing History |
| 2023-02-14 4:05 pm Sale |
2022-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
Point72 Asset Management, L.P. | 0 0.000% |
-470,000 (Position Closed) |
Filing History |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Minerva Neurosciences, Inc. NERV |
The Vanguard Group | 193,938 3.630% |
193,938 (New Position) |
Filing History |
| 2023-02-01 11:16 am Purchase |
2022-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
FEDERATED HERMES INC. FHI |
1,201,275 22.500% |
1,201,275 (New Position) |
Filing History |
| 2022-08-23 4:38 pm Purchase |
2022-08-22 | 13G | Minerva Neurosciences, Inc. NERV |
Point72 Asset Management, L.P. | 470,000 8.800% |
470,000 (New Position) |
Filing History |
| 2022-02-14 1:53 pm Unchanged |
2021-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
FEDERATED HERMES INC. FHI |
1,201,275 22.500% |
0 (Unchanged) |
Filing History |
| 2022-02-11 09:06 am Sale |
2021-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
Luthringer Remy | 132,470 2.500% |
-268,565 (-66.97%) |
Filing History |
| 2022-02-10 08:27 am Sale |
2021-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
The Vanguard Group | 503,218 9.420% |
-35,206 (-6.54%) |
Filing History |
| 2021-11-24 09:13 am Sale |
2021-11-24 | 13G | Minerva Neurosciences, Inc. NERV |
Assenagon Asset Management S.A. | 173,186 3.240% |
-586,978 (-77.22%) |
Filing History |
| 2021-11-24 09:11 am Purchase |
2021-11-23 | 13G | Minerva Neurosciences, Inc. NERV |
Assenagon Asset Management S.A. | 760,164 14.230% |
760,164 (New Position) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Minerva Neurosciences, Inc. NERV |
BLACKROCK INC BLK |
50,808 1.000% |
-225,591 (-81.62%) |
Filing History |
| 2021-02-16 06:02 am Purchase |
2020-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
Luthringer Remy | 401,035 7.500% |
53,023 (+15.24%) |
Filing History |
| 2021-02-12 12:50 pm Unchanged |
2020-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
FEDERATED HERMES INC. FHI |
1,201,275 22.520% |
0 (Unchanged) |
Filing History |
| 2021-02-10 1:42 pm Purchase |
2021-01-29 | 13G | Minerva Neurosciences, Inc. NERV |
The Vanguard Group | 538,424 10.090% |
7,164 (+1.35%) |
Filing History |
| 2021-02-10 11:28 am Purchase |
2020-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
The Vanguard Group | 531,260 9.960% |
531,260 (New Position) |
Filing History |
| 2021-02-08 10:27 am Sale |
2021-02-05 | 13G | Minerva Neurosciences, Inc. NERV |
FMR CORP | 49,435 0.926% |
-203,929 (-80.49%) |
Filing History |
| 2021-01-29 5:23 pm Purchase |
2020-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
BLACKROCK INC BLK |
276,399 5.200% |
12,507 (+4.74%) |
Filing History |